Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) EBITDA (2025 - 2026)

Updated

Kardigan's EBITDA came in at -$63.16 million for Q3 2026, compared with -$57.84 million a year earlier.

Analysis

Kardigan (KARD) EBITDA (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Kardigan reported EBITDA of -$295.53 million; for FY2025, it came in at -$197.64 million.

  • Going back by year, EBITDA was -$96.65 million in FY2024.
  • The five-year range for quarterly EBITDA is -$117.13 million (Q2 2026) to -$25.68 million (Q1 2025).
  • Business Quant data shows KARD's EBITDA at -$117.13 million (Q2 2026), -$57.12 million (Q1 2026) and -$58.12 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 8.16 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 4.20 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 7.05 Bn
10 Kardigan 1.29 Bn -398.44 Mn - -63.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -63.16 Mn
Jun 30, 2026 -117.13 Mn
Mar 31, 2026 -57.12 Mn
Jun 30, 2025 -56.00 Mn
Mar 31, 2025 -25.68 Mn
API Access

Kardigan EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=KARD&period=max&api_key=YOUR_API_KEY